Actively Recruiting
Studying Brain Injury Markers in Spinal Fluid and Blood After Cardiac Arrest and Their Impact on Recovery
Led by Tang Ziren · Updated on 2025-02-21
30
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a single-center, prospective observational study to explore the relationship between brain injury biomarkers found in cerebrospinal fluid and blood following cardiac arrest. The study focuses on patients who have undergone successful cardiopulmonary resuscitation and are receiving targeted temperature management in an emergency intensive care unit. The aim is to better understand how these biomarkers relate to neurological outcomes after cardiac arrest. Participants will receive standardized targeted temperature management after return of spontaneous circulation ROSC. Lumbar puncture examinations will be performed immediately after ROSC, at 24 hours and 72 hours during hypothermia, and after rewarming, to collect cerebrospinal fluid samples. Blood samples will also be collected alongside lumbar punctures. These samples will be tested for various brain injury markers using enzyme-linked immunosorbent assay ELISA. Throughout the study, patients will be closely monitored with routine cerebrospinal fluid and blood tests. Neurological function will be evaluated over three months using the Pittsburgh Cerebral Performance Category CPC scale. Samples will be stored securely at -80C for detailed analysis. This follow-up period aims to assess the neurological prognosis and provide insights into brain injury recovery after cardiac arrest.
CONDITIONS
Brief Title
The Relationship Between Brain Injury Biomarkers in Cerebrospinal Fluid and Blood of Patients After Cardiac Arrest and Prognosis
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here